Sperm Banking and Storage Billing in Fertility Practices

Sperm banking occupies an underappreciated corner of fertility billing. The procedures are straightforward clinically, but the billing complexity comes from three overlapping variables: the reason the patient is banking (oncofertility preservation vs. infertility workup vs. elective banking before a vasectomy), which entity is doing the billing (clinic vs. andrology lab vs. both under a split tax ID arrangement), and whether the male partner is even covered under the insurance plan in question. Get any one of those variables wrong and the claim either denies or gets mis-routed into a benefit bucket that will never pay.

This guide covers every billing touchpoint in the sperm banking revenue cycle: the initial semen analysis, the cryopreservation procedure, annual storage fees, and thawing charges at the time of insemination or IVF. It addresses ICD-10 selection for both oncofertility and infertility indications, common denial patterns, and the payer-specific rules that determine whether any of these services are covered at all.

CPT Codes for Sperm Banking and Related Services

The andrology CPT codes used in sperm banking are drawn from the 89000-series pathology and laboratory codes. Understanding which code applies to which step of the process — and when multiple codes can be reported on the same date of service — is the foundation of clean sperm banking claims.

A common billing error is reporting CPT 89259 (cryopreservation) and CPT 89322 (semen analysis) as separate line items when the full analysis was performed solely to process the specimen for banking rather than as a standalone diagnostic test. Most payer edits allow both codes on the same DOS because the semen analysis informs how many vials to freeze and at what concentration — but some payers bundle 89322 into 89259 for the same date. Review your remittance patterns and payer-specific CCI edits before assuming both codes will pay concurrently.

ICD-10 Code Selection: Oncofertility vs. Infertility Indication

The ICD-10 code on a sperm banking claim does more work than on most fertility claims because it determines not just coverage eligibility but which benefit bucket — medical vs. fertility — the claim is routed into. Oncofertility banking claims should never carry a primary infertility diagnosis; doing so strips the medical necessity argument that is the only viable path to reimbursement for many plans.

For oncofertility cases, always list the cancer diagnosis as the first-listed ICD-10 code. Z31.62 should appear as an additional diagnosis. Some payers specifically require the oncology diagnosis to be primary and will deny if the fertility preservation code leads, even when both are present. Train front-end staff to pull the active oncology diagnosis from the chart before building the claim — never default to N46.9 as primary for a patient whose banking indication is gonadotoxic treatment.

What Insurance Actually Covers: A Realistic Assessment

Sperm banking coverage varies dramatically by plan type, state mandate, and clinical indication. Understanding what different payers will and will not reimburse helps set accurate patient financial expectations before services are rendered and reduces denial volume from non-covered services billed to insurance.

• Oncofertility banking (pre-chemotherapy or pre-radiation): Covered by an increasing number of commercial plans. States including California (SB-729), New York, Illinois, New Jersey, and Massachusetts have enacted mandates that may include fertility preservation for iatrogenic infertility. Coverage typically includes CPT 89259 and 89322. Annual storage fees are almost never included in mandate coverage.
• Infertility-indicated banking (azoospermia, severe oligospermia): Covered in states with comprehensive fertility mandates, particularly when banking is a required step before IVF or ICSI. Check the mandate language — some cover only the IVF procedure and include sperm prep as part of the lab bundle, treating andrology codes as embedded rather than separately billable.
• Elective banking (pre-vasectomy, military deployment, personal preference): Almost universally denied by commercial insurance. Self-pay pricing is the appropriate financial path. Document that the patient was informed of non-coverage before specimen collection.
• Annual storage fees: Rarely covered by any insurance plan, including in mandate states. Most payers explicitly exclude cryostorage fees from benefit coverage. Annual storage is almost always direct patient financial responsibility, billed outside the insurance workflow entirely.
• Thawing for IVF or IUI (CPT 89353): Typically covered when the associated IVF or IUI procedure is covered. Verify whether the payer bundles thaw into the global IVF lab fee or allows it as a separately payable line item — contract terms vary significantly across fertility benefit managers and commercial payers.

Annual Sperm Storage Fee Billing

Annual sperm storage is an almost entirely self-pay revenue stream, which creates its own administrative requirements. Because most practices bill storage annually or semi-annually on a cycle that does not align with the standard insurance billing workflow, storage billing is frequently handled inconsistently — missed invoices, manual payment tracking, and uncollected fees from patients who have changed contact information are common leakage points.

From a coding standpoint, there is no universally accepted CPT code for annual sperm storage. Practices typically use one of three approaches: (1) an unlisted procedure code (89999) with a written description on the claim or invoice; (2) a flat-rate self-pay invoice processed entirely outside of the claims system; or (3) a HCPCS S-code if billing a Medicaid managed care organization or a plan that accepts S-codes — though S-codes are not accepted by Medicare or most commercial payers. For practices with oncofertility patients whose insurance may theoretically extend to storage continuation, contact the payer directly before billing to ask whether a specific code is required and whether a separate annual authorization is needed.

Best practice for annual storage billing is to obtain a signed storage agreement at the time of initial banking. The agreement should specify: the annual storage fee, the renewal date, the payment method on file for automatic renewal, the disposition instructions if the patient fails to pay or cannot be reached, and the notification protocol for abandoned specimens. This agreement is the legal and financial basis for ongoing billing and should be reconfirmed in writing every three to five years for long-term storage patients.

Thawing and Sperm Preparation Billing in IVF and IUI Cycles

When a patient is ready to use banked sperm in a treatment cycle, the andrology lab performs one or more additional billable procedures: thawing the cryopreserved sample (CPT 89353), washing and preparing the sperm for insemination or IVF (CPT 89261 for basic wash; CPT 89264 for density gradient), and in ICSI cycles, individual sperm selection for microinjection (CPT 89280 or 89281). Understanding how these codes interact with the global IVF claim and the payer's lab bundling rules determines whether the andrology charges generate separate reimbursement or are absorbed into a bundled global payment.

Modifier 59 (or the more specific X-modifier XS — separate structure) is occasionally necessary when reporting 89353 alongside 89322 or 89261 on the same claim, particularly when payer CCI edits attempt to bundle these codes. Apply modifier 59 only when the procedures were genuinely distinct services: the semen analysis was a diagnostic evaluation and the cryopreservation or thawing was a separate therapeutic service performed on the same date. Do not apply modifier 59 to override a legitimate bundling edit when the codes describe overlapping work performed as part of a single procedure.

Oncofertility Billing: Prior Authorization and Documentation

Oncofertility banking claims represent the best-covered segment of sperm banking and also the segment most likely to have prior authorization requirements. Many commercial plans that cover oncofertility preservation require pre-authorization even for the initial banking procedure. In many payers' workflows, the authorization request should originate from the oncologist rather than the fertility clinic — the fertility clinic provides the procedure, but the medical necessity is established by the cancer diagnosis and the planned gonadotoxic treatment regimen.

• Obtain a copy of the oncologist's treatment plan documenting the gonadotoxic nature of the planned therapy — this is the primary medical necessity document for the auth request and the appeal file
• Request prior authorization before the banking procedure, never retroactively; retroactive auth for oncofertility banking is approved inconsistently and is often denied outright
• Include the cancer diagnosis code as the primary ICD-10 on the authorization request, not a fertility or infertility code — payers reviewing the request need to see the oncology context immediately
• Ask the payer during the authorization call whether storage fees are included in the authorization or whether a separate annual authorization is required to continue storage
• Confirm which provider entity is authorized — the fertility clinic, the andrology lab, or both — and that the authorized NPI matches the rendering provider NPI on the eventual claim
• Document the authorization number, the payer representative's name, the date and time of the call, and the specific CPT codes authorized; do not rely solely on a verbal authorization
• If the patient cannot produce fresh sperm (e.g., due to prior radiation or chemotherapy), electroejaculation or surgical sperm retrieval may be necessary — these require separate CPT codes and distinct authorization from standard banking

Common Denial Patterns and How to Prevent Them

Sperm banking claims fail for a predictable and preventable set of reasons. The following patterns account for the majority of denials in practices with active andrology programs, along with the upstream correction for each.

• Male patient not covered under the policy: The female partner is the subscriber and the male is not listed as a covered dependent. Prevention: verify the male partner's eligibility separately before banking — if he is not covered, collect self-pay at the time of service.
• Non-covered service — elective banking: No mandate coverage, no oncofertility indication documented. Prevention: collect payment before or at the time of service; do not bill insurance for elective banking without documented evidence of plan coverage.
• Missing prior authorization: Auth was not obtained before an oncofertility banking procedure. Prevention: build oncofertility banking into the prior auth workflow as a standard trigger — any patient with an active cancer diagnosis scheduled for sperm banking should auto-route to auth before the appointment.
• Incorrect primary diagnosis on oncofertility claim: Z31.62 or an infertility code appears as primary instead of the cancer diagnosis. Prevention: train billers to pull the oncology diagnosis from the patient chart for oncofertility encounters; never default to N46.9 as primary for a patient whose indication is gonadotoxic treatment.
• Bundling of semen analysis and cryopreservation: Payer edit bundles 89322 into 89259 on the same DOS. Prevention: review payer-specific CCI policies; apply modifier 59 only when documentation supports genuinely distinct services; appeal with supporting clinical notes when bundling is inappropriate.
• Timely filing missed on andrology charges: Andrology lab charges are billed on a delayed cycle and miss the payer's timely filing window. Prevention: establish hard billing cutoffs — andrology charges must be captured and submitted within 30 days of DOS regardless of internal workflow cycles.

Split Billing: Clinic vs. Andrology Lab

Many fertility practices operate their andrology lab under a separate CLIA number and sometimes a separate tax ID (EIN). When this is the case, sperm banking charges must be billed by the correct entity: the clinic bills for the physician's professional services, while the andrology lab bills for the laboratory procedures (89322, 89259, 89353). Submitting lab CPT codes under the clinic's EIN when the work was performed under the lab's CLIA certification is a compliance violation and a common audit finding in fertility practice reviews.

If the andrology lab and the clinic share a tax ID, the place of service code on the claim must accurately reflect where the laboratory work was performed — typically POS 81 (Independent Laboratory) or POS 11 (Office) depending on the configuration. Billing laboratory codes under POS 11 when the work was performed in a CLIA-certified independent lab may create post-payment audit liability. Verify your payer contracts and CMS place-of-service guidelines for lab billing before assuming POS 11 is correct for all andrology services billed under the clinic EIN.

Self-Pay Pricing and Financial Counseling Best Practices

Because a large portion of sperm banking — elective banking, annual storage, and services for uninsured male partners — is self-pay, clear financial counseling at the point of service is as important as accurate claim submission. Practices should maintain a written self-pay fee schedule specifically for andrology services that is provided to patients before specimen collection occurs.

• Initial banking fee: Clearly state whether this includes the semen analysis and the first vial freeze; price additional vials per vial or per session and disclose upfront
• Annual storage fee: Specify whether the fee covers a calendar year or an anniversary year; typical market range is $300–$600 per year per patient
• Thawing fee: Disclose before the patient begins a treatment cycle that thawing is a separate charge from the IVF or IUI procedure fee; patients who banked years earlier are frequently surprised by thawing charges at cycle start
• Expedited processing fee: If the practice offers same-day or rush banking for oncofertility patients starting treatment immediately, this premium is a separately billable service that should be quoted in advance
• Post-thaw analysis fee: Patients requesting viability confirmation after thaw, before committing to a cycle, should be quoted this fee separately from the thawing charge itself
• Specimen transport fee: If the patient needs specimens transferred to another facility for treatment, document and quote the transport and chain-of-custody handling fee before initiating the transfer

Reimbursement Benchmarks

Under the 2026 Medicare Physician Fee Schedule, CPT 89322 (complete semen analysis) is valued at approximately 0.57 total RVUs, translating to roughly $20–$24 at the national conversion factor. CPT 89259 (sperm cryopreservation) is valued at approximately 0.85 RVUs, translating to approximately $30–$35 at national rates. Commercial payer reimbursement for andrology codes typically runs 120%–180% of Medicare, placing commercial collection in the $35–$65 range for 89322 and $45–$75 for 89259 in most markets. Fertility benefit managers (Progyny, Carrot, WINFertility) often have negotiated rates for these codes that may differ significantly from standard commercial contracts — confirm the rates in each FBM contract separately.

CPT 89353 (thawing) is valued at approximately 0.45 RVUs under Medicare, generating roughly $16–$19 at national rates. Commercial reimbursement for 89353 is frequently higher on a relative basis because many payer fee schedules have not been updated to fully reflect current market rates for andrology services, and some FBM contracts carve this code out at a flat dollar rate negotiated independently of the standard fee schedule. Practices that are not tracking 89353 as a separate line item on their collections reports are likely missing reimbursement that is owed under contract but not being consistently billed.

Summary

Sperm banking billing requires parallel fluency in clinical andrology and insurance mechanics. The CPT codes are relatively straightforward, but the surrounding framework — who is the insured, what is the clinical indication, which benefit bucket applies, whether prior authorization was obtained, and which tax ID is on the claim — determines whether those codes generate revenue or generate denials. Oncofertility banking is the highest-value segment and the one most likely to be covered by commercial plans; invest in prior authorization workflows and precise ICD-10 selection. Annual storage is almost universally self-pay; invest in a structured storage agreement and an automated billing cycle with clear disposition policies. Thawing and preparation charges at the time of IVF are frequently under-billed because they are assumed to be bundled when they are not. Audit each of these revenue streams quarterly and you will find that andrology billing, done systematically, generates more net revenue than most practices currently capture.